The analysis of a new tumor-associated antigen, TSP-1, in the gene and protein expression levels
The analysis of a new tumor-associated antigen, TSP-1, in the gene and protein expression levels
批准号:
10672194
负责人:
KUROKI Masahide
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
血栓形成蛋白-1(TSP-1)是一种分子量为450,000的同源三聚体大分子,由活化的血小板释放,也由许多类型的细胞合成,包括内皮细胞、单核细胞、巨噬细胞、成纤维细胞和各种肿瘤细胞。虽然目前已报道了几种抗TSP-1的单克隆抗体,但对其特异性的详细描述尚不多见。其中6个为IgM型,4个为IgG 1型,还有IgG 3型。组织化学和血清学研究表明,这些单克隆抗体可用于免疫组化研究和/或检测各种癌症中TSP-1的血清水平。另一方面,TSP-1是细胞外基质(ECM)的一种成分,是一种粘附分子,能够结合各种游离大分子和多种类型的细胞。尽管许多报道描述了ECM蛋白的作用,但似乎很少有出版物描述TSP-1对免疫细胞的作用。在本研究中,我们还研究了TSP-1在植物血凝素存在下对体外培养的T细胞和抗原呈递细胞(APC)的影响,发现可溶性T细胞增殖和增殖以及增强APC分泌IL-10。
英文摘要
Thrombospodin-1 (TSP-1), a homotrimetric macromolecule with a molecular weight of 450,000, is released from activated platelets and also synthesized by many types of cells including endothelial cells, monocytes, macrophages, fibroblasts, and various tumor cells. Although several monoclonal antibodies (MAbs) to TSP-1 have been reported, only a few reports have described their detail specificity.In this study, we prepared 13 new monoclonal antibodies to TSP-1. Six of them were of the IgM variety, four were IgG1 and there were IgG3. Histochemical and serological characterization demonstrated that some of these MAbs are useful for immunohistochemical study and/or for determination or serum levels of TSP-1 in various cancers.On the other hand, TSP-1, a component of extracellular matrices (ECMs), is an adhesion molecule and capable of binding various free macromolecules and many types of cells. Although many reports described the effects of ECM proteins, there seem to be few publications describing the effects of TSP-1 on immune cells. In the present study, we also studied the influence of TSP-1 upon in vitro culture of T cells and antigen-presenting cells (APCs) in the presence of phytohemagglutinin and found that soluble T cell proliferation and proliferation and enhances IL-10 secretion by APCs.Taken together, the results obtained here indicate that TSP-1 may serve as a potential useful tumor maker and an immunosuppressive modulator possibly in inflammatory sites.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Miyajima-Uchida, H., Hayashi, H., Beppu, R., Kuroki, Mo., Arakawa, F., Kuroki, Ma.: "Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells"Invest. Ophthalmol. Vis. Sci.. 41. 561-567 (2000)
Miyajima-Uchida, H.、Hayashi, H.、Beppu, R.、Kuroki, Mo.、Arakawa, F.、Kuroki, Ma.:“人视网膜色素上皮细胞中血小板反应蛋白-1 的产生和积累”研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamura, K., Yuh, K., Sugyo, S., Kuroki, Ma., Shijo, H., Martsuoka, Y.: "Unresponsiveness of peripheral T cells induced by intrusion of apoptotic bodies derived from autologous T cells"Cell. Immunol.. 193. 147-154 (1999)
Nakamura, K.、Yuh, K.、Sugyo, S.、Kuroki, Ma.、Shijo, H.、Martsuoka, Y.:“自体 T 细胞衍生的凋亡小体侵入诱导的外周 T 细胞无反应”细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
別府理智子,黒木政秀,仙波垂水,山本貴文,富田能弘,荒川文子: "ヒトトロンボスポンジン-1に対するモノクローナル抗体の作製" 日本癌学会総会記事. 56・1. 581 (1997)
别府美智子、黑木雅英、仙场垂美、山本贵文、富田佳弘、荒川文子:“抗人血小板反应蛋白-1单克隆抗体的制备”日本癌症协会大会文章56·1(1997年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuroki, Ma., Xu, Z., Senba, T. and Arakawa, F.: "Recent Research Developments in Immunology, Vol.1"Research Signpost (Korala). 120 (1999)
Kuroki, Ma.、Xu, Z.、Senba, T. 和 Arakawa, F.:“免疫学最新研究进展,第 1 卷”研究路标 (Korala)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuroki,Ma.,Matsushita,H.,Matsumoto,H.,Hirose,Y.,Senda,T.and Yamamoto,T.:: "Nonspecific cross-reacting antigen-50/90(NCA-50/90)as a new tumor marker"Anticancer Res.. 19・6C. 5599-5606 (1999)
Kuroki, Ma.、Matsushita, H.、Matsumoto, H.、Hirose, Y.、Senda, T. 和 Yamamoto, T.:“非特异性交叉反应抗原 50/90 (NCA-50/90) 作为新肿瘤标志物“Anticancer Res.. 19・6C. 5599-5606 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Study on the Usefulness of the Novel Tumor Marker MK-1 in the Diagnosis and Therapy of Cancer
-
批准号:20590593
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:KUROKI Masahide
-
依托单位:
Generation and application of fully human antibodies to a new tumor-associated antigen, Ep-CAM
-
批准号:18590544
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.55万
-
财政年份:2006
-
负责人:KUROKI Masahide
-
依托单位:
Significance of a new tumor-associated antigen, MK-1, for diagnosis and therapy of cancer
-
批准号:16590468
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:KUROKI Masahide
-
依托单位:
Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen
-
批准号:14572195
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2002
-
负责人:KUROKI Masahide
-
依托单位:
A Specific Study for Clinical Application of a New Tumor-associated Antigen, MK-1,
-
批准号:12672261
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2000
-
负责人:KUROKI Masahide
-
依托单位:
Cloning of cDNA and establishment of an assay system for Mr 110,000 Ag
-
批准号:06672309
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1994
-
负责人:KUROKI Masahide
-
依托单位: